Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACT3: Fermagate in Hemodialysis Subjects With Hyperphosphataemia
NCT00436683Phase 2Completed
- Sponsor
- INEOS Healthcare Limited
- Start
- Feb 2007
- Primary completion
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fermagate in hyperphosphatemia, sponsored by INEOS Healthcare Limited. Started Feb 2007; status: completed.
02
Drugs
fermagate
03
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on NCT00436683.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00436683.